• APHL

    APHL

    APHL strengthens public health laboratory systems in the US and globally. More.
Our Work

APHL represents state and local governmental health labs. Its members monitor and detect health threats to protect US health and safety.


Featured Resources

 

 

Building global systems http://redesign.dev.aphl.org/aboutAPHL/Lists/Highlighted Content/DispForm.aspx?ID=3Building global systems <img alt="" src="/PublishingImages/About%20APHL%204.gif" style="BORDER:0px solid;" />http://redesign/programs/global_health/Pages/default.aspx, http://redesign.dev.aphl.org/programs/global_health/Pages/default.aspx
Delivering e-data http://redesign.dev.aphl.org/aboutAPHL/Lists/Highlighted Content/DispForm.aspx?ID=2Delivering e-data <img alt="" src="/PublishingImages/About%20APHL%203.gif" style="BORDER:0px solid;" />http://redesign/programs/informatics/Pages/default.aspx, http://redesign.dev.aphl.org/programs/informatics/Pages/default.aspx
Detecting infectious diseaseshttp://redesign.dev.aphl.org/aboutAPHL/Lists/Highlighted Content/DispForm.aspx?ID=1Detecting infectious diseases<img alt="" src="/PublishingImages/About%20APHL%202.gif" style="BORDER:0px solid;" />http://redesign/programs/infectious_disease/Pages/default.aspx, http://redesign.dev.aphl.org/programs/infectious_disease/Pages/default.aspx

 

 

2015 All-Hazards Survey Reporthttp://redesign.dev.aphl.org/aboutAPHL/publications/Documents/PHPR-2015-All-Hazards-52016-digital.pdf2015 All-Hazards Survey ReportEach year, APHL surveys PHLs to assess their readiness to respond to threats and identify challenges that affect rapid response. This year's survey covers the 12-month period from 7/1/14 - 6/30/15, representing FY14 CDC PHEP Cooperative Agreement, BP 3.
Guidance for State Medical Cannabis Testinghttp://redesign.dev.aphl.org/aboutAPHL/publications/Documents/EH-Guide-State-Med-Cannabis-052016.pdfGuidance for State Medical Cannabis Testing
MTBC Drug Susceptibility Testing: EMBhttp://redesign.dev.aphl.org/aboutAPHL/publications/Documents/ID-MTBC_DrugSusceptibility_0216.pdfMTBC Drug Susceptibility Testing: EMBA discussion of issues surrounding the use of the anti-tuberculosis drug Ethambutol, or EMB, including recommended dose, EMB drug susceptibility testing and test methods, and reproducibility of susceptibility testing for EMB.
MTBC Drug Susceptibility Testing: PZAhttp://redesign.dev.aphl.org/aboutAPHL/publications/Documents/ID-PZA_WhitePaper_0216.pdfMTBC Drug Susceptibility Testing: PZAA discussion about the use of Pyrazinimide, or PZA, as first-line therapy for treatment of Mycobacterium tuberculosis complex, including mechanism of action, reproducibility of susceptibility testing, and impact on clinical outcomes.